[go: up one dir, main page]

JP3547155B2 - Active oxygen suppressant - Google Patents

Active oxygen suppressant Download PDF

Info

Publication number
JP3547155B2
JP3547155B2 JP28500393A JP28500393A JP3547155B2 JP 3547155 B2 JP3547155 B2 JP 3547155B2 JP 28500393 A JP28500393 A JP 28500393A JP 28500393 A JP28500393 A JP 28500393A JP 3547155 B2 JP3547155 B2 JP 3547155B2
Authority
JP
Japan
Prior art keywords
active oxygen
extract
production example
water
ethanol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP28500393A
Other languages
Japanese (ja)
Other versions
JPH07138174A (en
Inventor
恒雄 難波
征雄 服部
健次 下村
佳代 中谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mikimoto Pharmaceutical Co Ltd
Original Assignee
Mikimoto Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mikimoto Pharmaceutical Co Ltd filed Critical Mikimoto Pharmaceutical Co Ltd
Priority to JP28500393A priority Critical patent/JP3547155B2/en
Publication of JPH07138174A publication Critical patent/JPH07138174A/en
Application granted granted Critical
Publication of JP3547155B2 publication Critical patent/JP3547155B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)

Description

【0001】
【産業上の利用分野】
本発明は化粧品、医薬品、食品等に応用され得る植物由来の人体に安全性のある活性酸素抑制剤に関する。
【0002】
【従来の技術】
トラギア インボルクラタ(Tragia involucrata)は、双子葉植物網、離弁花亜網、ドウダイグサ科の植物でインド、スリランカ、ミャンマー、中国に分布し、スリランカでは低地の荒れ地によく分布する。インドでは発汗、喉頭炎、気管支炎、肺炎、癩病などに利用されている。
【0003】
【発明が解決しようとする課題】
本発明の目的は、天然物で人体に安全であることが分かっており、しかも強い活性酸素抑制作用のある物質で、できれば活性酸素抑制作用以外の効果も発揮するような活性酸素抑制剤を提供することにある。
【0004】
【課題を解決するための手段】
本発明者らは、前記の課題を解決するため、すでに多年にわたって食用に供され、人体に対する安全性が確認されている植物をスクリーニングして調べ、活性酸素抑制剤として利用価値のあるものを検討した。その結果、トラギア インボルクラタの溶媒抽出物が化粧品原料として、或いは医薬部外品として、非常に活性酸素抑制に有効性を有することを見い出した。
【0005】
すなわち、本発明はトラギア インボルクラタ(Tragia involucrata)の溶媒抽出物を含む活性酸素抑制剤である。
【0006】
これらの植物の利用方法としては、水或いは親水性有機溶媒例えば、エタノール、メタノール、アセトン等で抽出する。しかしながら、化粧品、医薬品、食品等の原料の抽出であるから、水或いはエタノール或いはこれの混合溶媒での抽出が好ましいのは当然である。また、場合によっては、グリセリン、1,3ブチレングリコール、プロピレングリコール、等の多価アルコール又は多価アルコールと水との混液も抽出に利用できる。またさらに凍結乾燥して粉体として利用することも利用方法によっては有効である。
【0007】
この物質を他の化粧品原料例えばスクワラン、ホホバ油等の液状油、ミツロウ、セチルアルコール等の固体油、各種の活性剤、グリセリン、1,3ブチレングリコール等の保湿剤や各種薬剤等を添加してさまざまな剤形の化粧料を調製することができる。例えばローション、クリーム、乳液、パック等で目的に応じて利用形態を考えればよい。
【0008】
空気中には酸素があり、これがないと生物(嫌気性のものを除く)は存在しえない。しかし酸素は紫外線や酵素等の影響を受けて活性酸素になる。活性酸素は脂肪酸を酸化し過酸化物を生成させる。生体の生体膜のリン脂質も酸化させ、障害を与える。その上、生成した過酸化物と活性酸素はDNAに損傷を与え、老化を促進するといわれている。この活性酸素は、チロシンからメラニンを作る機構にも影響を与え皮膚の黒化にも関与している。この活性酸素を抑制することは皮膚にとって重要な、言い換えれば化粧料に求められる重要な要素である。
【0009】
【実施例】
以下に実際の利用方法である実施例を記載するが、本発明はこの実施例によって何ら限定されるものではない。本発明及び参考例で使用したアザディラクト インディカ(Azadirachdt indica)、トラギア インボルクラタ(Tragia involucrata)の抽出物の製造例を次に示す。
【0010】
(参考製造例1)
アザディラクト インディカ(Azadirachdt indica)の樹皮(乾燥品)を10gに精製水300mlを加えて3時間加熱する。これを放冷した後濾過後凍結乾燥した。
【0011】
(製造例
トラギア インボルクラタ(Tragia involucrata)の全草(乾燥品)を10gにエタノール300mlを加えて時々撹拌しつつ5日間放置した。これを濾過後凍結乾燥した。
【0012】
(製造例
トラギア インボルクラタ(Tragia involucrata)の全草(乾燥品)を10gに50%エタノール水溶液300mlを加えて時々撹拌しつつ5日間放置した。これを濾過後凍結乾燥した。
【0013】
(製造例
トラギア インボルクラタ(Tragia involucrata)の全草(乾燥品)を10gに精製水300mlを加えて3時間加熱する。これを放冷した後濾過後凍結乾燥した。
【0014】
(実施例)クリーム (重量%)
A スクワラン 20.0
オリーブ油 2.0
ミンク油 1.0
ホホバ油 5.0
ミツロウ 5.0
セトステアリルアルコール 2.0
グリセリンモノステアレート 1.0
ソルビタンモノステアレート 2.0
製造例抽出物 1.0
B 精製水 47.9
ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0
ポリオキシエチレン(60E.O.)硬化ヒマシ油 1.0
グリセリン 5.0
1.0%ヒアルロン酸ナトリウム水溶液 5.0
パラオキシ安息香酸メチル 0.1
AとBをそれぞれ計量し、70℃まで加温し、BにAを撹拌しつつ徐々に加えたのち、ゆっくり撹拌しつつ30℃まで冷却した。
【0015】
(実施例)ローション (重量%)
オリーブ油 0.5
製造例抽出物 0.5
ポリオキシエチレン(20E.O.)ソルビタンモノステアレート 2.0
ポリオキシエチレン(60E.O.)硬化ヒマシ油 2.0
エタノール 10.0
1.0%ヒアルロン酸ナトリウム水溶液 5.0
精製水 80.0
【0016】
(実施例3)
実施例3は実施例1の製造例1の抽出物を製造例3の抽出物に変え作成したクリーム。
【0017】
(参考例1)
参考例1は実施例2の製造例2の抽出物を参考製造例1の抽出物に変え作成したローション。
【0018】
(活性酸素抑制試験)
活性酸素を抑制する効果を測定する方法は各種あるが、今回以下の方法を利用した。

Figure 0003547155
上の試薬の混合物を2.4ml、検体を0.3ml加えて、キサンチンオキシナーゼ(予め検体を水とし、実験するとき、吸光度が1分当たり0.02前後上昇するように上記のリン酸カリウム緩衝液で調整しておく)液を0.3ml加えて直ちに吸光度(560nm)を測定する。(測定は2分位し、直線性を確認する。)
試算式 阻害率=((A−B)/A)×100
A:検体を水としたときの1分当たりの吸光度の変化
B:検体の1分当たりの吸光度の変化
濃度段階を数段階行い、50%活性酸素生成阻害濃度を探した。検体の作成方法は前記製造例(凍結乾燥品)を適当な濃度の水溶液(溶解しにくい場合はエタノールを加えて溶解したのち精製水を加えて、エバポレートし、エタノールを除去したのち適当な濃度%になるように調製した)とした。その結果を表1に示す。
【0019】
【表1】
Figure 0003547155
【0020】
(使用テスト)
女性4名づつの顔面を左右に分け、一方を実施例、もう一方を比較例として毎日、1回以上使用してもらって、3月後、アンケートした。なお、比較例は実施例より製造例の各種の抽出物を水にかえたものである。(比較例1,2)なお、20名を5班にわけ、下記の表2の試料を使って実験した。
【0021】
【表2】
Figure 0003547155
判定基準は以下のようでこの評点の合計値をもって評価し、その結果をまとめたのが以下の表3である。
実施例の方が非常によい 3
実施例の方がかなりよい 2
実施例の方がややよい 1
差がない 0
比較例の方がややよい −1
比較例の方がかなりよい −2
比較例の方が非常によい −3
【0022】
【表3】
Figure 0003547155
【0023】
【発明の効果】
本発明のトラギア インボルクラタのアルコール、水等の溶媒による抽出物は活性酸素抑制試験、使用テストの結果より明らかなように、極く微量でも活性酸素抑制効果が大きく、化粧品に配合した場合、肌荒れを防止し、肌のつや、肌のはりを保持する効果が大きい。長期にわたり、医薬品として使用されてきており、人体に対する安全性が保証されている。[0001]
[Industrial applications]
TECHNICAL FIELD The present invention relates to a plant-derived active oxygen inhibitor that is safe for the human body and can be applied to cosmetics, pharmaceuticals, foods, and the like.
[0002]
[Prior art]
Tragia involculata is a plant belonging to the dicotyledonous net, the leaf-flowering sub-net and the Euphorbiaceae family in India, Sri Lanka, Myanmar and China. In Sri Lanka, it is widely distributed in lowland wasteland. In India, it is used for sweating, laryngitis, bronchitis, pneumonia, leprosy, etc.
[0003]
[Problems to be solved by the invention]
An object of the present invention is to provide an active oxygen inhibitor which is a natural product, which is known to be safe for the human body, and which has a strong active oxygen suppressing effect, and preferably exerts an effect other than the active oxygen suppressing effect. Is to do.
[0004]
[Means for Solving the Problems]
The present inventors have screened and examined plants that have been used for food for many years and have been confirmed to be safe for the human body to solve the above-mentioned problems, and examined those that are useful as active oxygen inhibitors. did. As a result, the solvent extract of preparative Ragia Inborukura data as a cosmetic raw material, or as a quasi-drug, was found to have efficacy in the very active oxygen inhibited.
[0005]
That is, the present invention is an active oxygen inhibitor containing a solvent extract of preparative Ragia Inborukurata (Tragia involucrata).
[0006]
As a method for utilizing these plants, extraction is performed with water or a hydrophilic organic solvent such as ethanol, methanol, or acetone. However, it is natural that extraction with water, ethanol, or a mixed solvent thereof is preferable because the extraction of raw materials for cosmetics, pharmaceuticals, foods, and the like is performed. In some cases, a polyhydric alcohol such as glycerin, 1,3 butylene glycol, propylene glycol, or a mixture of polyhydric alcohol and water can also be used for extraction. It is also effective to freeze-dry and use it as a powder depending on the method of use.
[0007]
This material is added with other cosmetic ingredients such as liquid oils such as squalane and jojoba oil, solid oils such as beeswax and cetyl alcohol, various activators, humectants such as glycerin and 1,3 butylene glycol, and various chemicals. Various dosage forms of cosmetics can be prepared. For example, a use form may be considered depending on the purpose, such as a lotion, a cream, a milky lotion, and a pack.
[0008]
There is oxygen in the air, without which organisms (except anaerobic ones) cannot exist. However, oxygen becomes active oxygen under the influence of ultraviolet rays and enzymes. Active oxygen oxidizes fatty acids to form peroxides. Phospholipids in biological membranes of living organisms also oxidize and cause damage. In addition, it is said that the generated peroxide and active oxygen damage DNA and accelerate aging. This active oxygen affects the mechanism of producing melanin from tyrosine and is also involved in skin darkening. Suppressing this active oxygen is important for the skin, in other words, an important factor required for cosmetics.
[0009]
【Example】
An embodiment which is an actual use method will be described below, but the present invention is not limited to the embodiment. Production examples of extracts of Azadirachdt indica and Tragia involclata used in the present invention and Reference Examples are shown below.
[0010]
(Reference Production Example 1)
300 g of purified water is added to 10 g of the bark of Azadirachdt indica (dry product), and the mixture is heated for 3 hours. This was allowed to cool, filtered, and lyophilized.
[0011]
(Production Example 1 )
300 ml of ethanol was added to 10 g of the whole plant (dried product) of Tragia involculata, and the mixture was allowed to stand for 5 days with occasional stirring. This was filtered and freeze-dried.
[0012]
(Production Example 2 )
To 10 g of a whole plant (dried product) of Tragia involclata was added 300 ml of a 50% aqueous ethanol solution, and the mixture was allowed to stand for 5 days with occasional stirring. This was filtered and freeze-dried.
[0013]
(Production Example 3 )
300 ml of purified water is added to 10 g of the whole plant (dried product) of Tragia involculata, and the mixture is heated for 3 hours. This was allowed to cool, filtered, and lyophilized.
[0014]
(Example 1 ) Cream (% by weight)
A squalane 20.0
Olive oil 2.0
Mink oil 1.0
Jojoba oil 5.0
Beeswax 5.0
Cetostearyl alcohol 2.0
Glycerin monostearate 1.0
Sorbitan monostearate 2.0
Production Example 1 Extract 1.0
B Purified water 47.9
Polyoxyethylene (20EO) sorbitan monostearate 2.0
Polyoxyethylene (60EO) hydrogenated castor oil 1.0
Glycerin 5.0
1.0% aqueous sodium hyaluronate solution 5.0
Methyl paraoxybenzoate 0.1
A and B were each weighed and heated to 70 ° C., A was gradually added to B with stirring, and then cooled to 30 ° C. with slow stirring.
[0015]
(Example 2 ) Lotion (% by weight)
Olive oil 0.5
Production Example 2 Extract 0.5
Polyoxyethylene (20EO) sorbitan monostearate 2.0
Polyoxyethylene (60EO) hydrogenated castor oil 2.0
Ethanol 10.0
1.0% aqueous sodium hyaluronate solution 5.0
Purified water 80.0
[0016]
(Example 3)
Example 3 is a cream prepared by changing the extract of Production Example 1 of Example 1 to the extract of Production Example 3.
[0017]
(Reference Example 1)
Reference Example 1 is a lotion prepared by changing the extract of Production Example 2 of Example 2 to the extract of Reference Production Example 1.
[0018]
(Active oxygen suppression test)
There are various methods for measuring the effect of suppressing active oxygen, but the following method was used this time.
Figure 0003547155
Add 2.4 ml of the mixture of the above reagents and 0.3 ml of the sample, and add xanthine oxynase (the above-mentioned potassium phosphate so that the absorbance increases by about 0.02 per minute when the sample is made into water before the experiment). Add 0.3 ml of the solution (adjusted with a buffer solution) and immediately measure the absorbance (560 nm). (Measurement is divided into two and linearity is confirmed.)
Trial calculation formula Inhibition rate = ((AB) / A) × 100
A: Change in absorbance per minute when the sample was water B: Change in absorbance per minute of the sample Several steps were performed to find the 50% active oxygen production inhibitory concentration. A sample was prepared by dissolving the above-mentioned production example (freeze-dried product) in an aqueous solution having an appropriate concentration (if it was difficult to dissolve, adding ethanol to the solution, adding purified water, evaporating the solution, removing the ethanol, and then removing an appropriate concentration of Was prepared so that Table 1 shows the results.
[0019]
[Table 1]
Figure 0003547155
[0020]
(Use test)
The face of each of four women was divided into left and right, one was used as an example and the other was used as a comparative example, and used once or more every day. In the comparative examples, various extracts of the production examples were replaced with water from the examples. (Comparative Examples 1 and 2) Twenty people were divided into five groups, and experiments were performed using the samples shown in Table 2 below.
[0021]
[Table 2]
Figure 0003547155
The criterion is as follows, and the evaluation was made based on the total value of the scores, and the results are summarized in Table 3 below.
Example is much better 3
Example is considerably better 2
Example is slightly better 1
No difference 0
Comparative example is slightly better -1
Comparative example is much better -2
Comparative example is much better -3
[0022]
[Table 3]
Figure 0003547155
[0023]
【The invention's effect】
DOO Ragia Inborukura other alcohols, extract with solvents such as water of the present invention the active oxygen inhibition test, as is clear from the results of use tests, large active oxygen inhibitory effect in trace amount, when incorporated in cosmetics, It has a great effect of preventing rough skin and keeping skin shine and skin scalp. It has been used as a pharmaceutical for a long time, and its safety to the human body is guaranteed.

Claims (1)

ラギア インボルクラタ(Tragia involucrata)の溶媒抽出物を含む活性酸素抑制剤。Active oxygen inhibitor containing a solvent extract of preparative Ragia Inborukurata (Tragia involucrata).
JP28500393A 1993-11-15 1993-11-15 Active oxygen suppressant Expired - Fee Related JP3547155B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28500393A JP3547155B2 (en) 1993-11-15 1993-11-15 Active oxygen suppressant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28500393A JP3547155B2 (en) 1993-11-15 1993-11-15 Active oxygen suppressant

Publications (2)

Publication Number Publication Date
JPH07138174A JPH07138174A (en) 1995-05-30
JP3547155B2 true JP3547155B2 (en) 2004-07-28

Family

ID=17685892

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28500393A Expired - Fee Related JP3547155B2 (en) 1993-11-15 1993-11-15 Active oxygen suppressant

Country Status (1)

Country Link
JP (1) JP3547155B2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3487619B2 (en) * 1993-11-17 2004-01-19 御木本製薬株式会社 5α-reductase inhibitor
US20090181113A1 (en) 2005-11-28 2009-07-16 Apptec, Inc. Compositions for the reversal of stratum granulosum in keratinization disorders
US7666450B2 (en) * 2007-12-04 2010-02-23 Apptec, Inc. Herbal compositions for the regression of chronic inflammatory skin disorders

Also Published As

Publication number Publication date
JPH07138174A (en) 1995-05-30

Similar Documents

Publication Publication Date Title
JPH08119869A (en) Active oxygen suppressor
JP3193441B2 (en) Whitening cosmetics
JP3647054B2 (en) Antioxidant
JP3558349B2 (en) Whitening cosmetics
JP3547155B2 (en) Active oxygen suppressant
JP3496967B2 (en) Antiplasmin agent
JP2600036B2 (en) Cosmetics
JP3235922B2 (en) Cosmetics
JP2690421B2 (en) Cosmetics
JPH0687731A (en) Cosmetic
JP3235919B2 (en) Cosmetics
JPH05306213A (en) Cosmetic
JP3545057B2 (en) Cosmetics
JP3667376B2 (en) Hyaluronidase inhibitor
JP3487617B2 (en) Cosmetics
JP3113009B2 (en) Whitening cosmetics
JP3792745B2 (en) Tyrosinase inhibitor
JP2774882B2 (en) Whitening and anti-aging cosmetics
JP2778855B2 (en) Cosmetics
JPH0597653A (en) Cosmetic
JPH08333270A (en) Cell activator
JP3408339B2 (en) Cosmetics
JPH0597649A (en) Cosmetic
JPH05306215A (en) Cosmetic
JP3461921B2 (en) Cosmetics

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040113

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20040311

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20040406

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20040413

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313115

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees